Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L

Journal of Experimental Medicine

Volumn 183, Issue 4, 1996, Pages 1331-1338

  Bevec, Tadeja ^a   Stoka, Veronika ^a   Pungerčič, Galina ^a   Dolenc, Iztok ^a   Turk, Vito ^a  

^a JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CATHEPSIN H; CATHEPSIN L; CATHEPSIN S; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PAPAIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EQUILIBRIUM CONSTANT; HUMAN; LYSOSOME; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

AMINO ACID SEQUENCE; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; ENDOPEPTIDASES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; KIDNEY; LYSOSOMES; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN BINDING;

EID: 0029924123     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.4.1331     Document Type: Article

References (45)

1. Germain, R.N., and D.H. Margulies. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:403-450.
2. Jones, P., D. Murphy, D. Hewgill, and H. McDevitt. 1979. Detection of a common polypeptide chain in I-A and I-E subregion immunoprecipitates. Mol. Immunol. 16:51-60.
3. Blum, J.S., and P. Cresswell. 1988. Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc. Natl. Acad. Sci. USA. 85:3975-3979.
4. Neefjes, J., V. Stollorz, P. Peters, H. Geuze, and H. Ploegh. 1990. The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell. 61:171-183.
5. Peterson, M., and J. Miller. 1990. Invariant chain influences the immunological recognition of MHC class II molecules. Nature (Lond.). 345:172-174.
6. Anderson, M.S., and J. Miller. 1992. Invariant chain can function as a chaperone protein for class II MHC molecules. Proc. Natl. Acad. Sci. USA. 89:2282-2286.
7. Roche, P., and P. Cresswell. 1990. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature (Lond.). 345:615-618.
8. Bakke, O., and B. Dobberstein. 1990. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell. 63:707-716.
9. Odorizzi, C.G., I.S. Trowbridge, L. Xue, C.R. Hopkins, C.D. Davis, and J.F. Collawn. 1994. Sorting signals in the MHC class II Ii cytoplasmic tail and trarismembrane region determine trafficking to an endocytic processing compartment. J Cell Biol. 126:317-330.
10. Pieters, J., H. Horstmann, O. Bakke, G. Griffiths, and J. Lipp. 1991. Intracellular transport and localization of MHC class II molecules and associated invariant chain. J Cell Biol. 115: 1213-1223.
11. Morton, P.A., M.L. Zacheis, K.S. Giacoletto, J.A. Manning, and B.D. Schwartz. 1995. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells. J. Immunol. 154: 137-150.
12. Roche, P.A., and P. Cresswell. 1991. Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc. Natl. Acad Sci USA. 88:3150-3154.
13. Reyes, V.E., S. Lu, and R.E. Humphreys. 1991. Cathepsin B cleavage of Ii from class II MHC α- and β-chains. J. Immunol. 146:3877-3880.
14. Marić, M.A., M.D. Taylor, and J.S. Blum. 1994. Endosomal aspartic proteinases are required for invariant-chain processing. Proc. Natl. Acad. Sci. USA. 91:2171-2175.
15. Ojcius, D.M., L. Gapin, J.M. Kanellopoulos, and P. Kourilsky. 1994. Is antigen processing guided by MHC molecules? FASEB (Fed. Am. Soc. Exp. Biol) J. 8:974-978.
16. Adormi, L., S. Muller, and F. Cardinaux. 1988. In vivo competition between self peptides and foreign antigens in T-cell activation. Nature (Lond.). 334:623-625.
17. Gorvel, J.P., J.M. Escola, E. Stang, and O. Bakke. 1995. Invariant chain induces a delayed transport from early to late endosomes. J. Biol. Chem. 270:2741-2746.
18. Peters, P.J., J.J. Neefjes, V. Oorschot, H.L. Ploegh, and H.J. Geuze. 1991. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature (Lond.). 349:669-676.
19. Tulp, A., D. Verwoerd, B. Dobberstein, H.L. Ploegh, and J. Pictcrs. 1994. Isolation and characterization of the intracellular MHC class II compartment. Nature (Lond.). 349:120-126.
20. Strubin, M., C. Berte, and B. Mach. 1986. Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen-associated invariant chain. EMBO (Eur. Mol. Biol. Organ ) J. 5:3483-3488.
21. Malthiéry, Y., and S. Lissitzky. 1987. Primary structure of human thyroglobulin deduced from the sequence of its 8448-base complementary DNA. Eur J. Biochem. 165:491-498.
22. Kämpgen, E., N. Koch, F. Koch, P. Stöger, C. Heufler, G. Schuler, and N. Romani. 1991. Class II MHC molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture. Proc. Natl. Acad. Sci. USA. 88:3014-3018.
23. Freisewinkel, I.M., K. Schneck, and N. Koch. 1993. The segment of invariant chain that is critical for association with MHC class II molecules contains the sequence of peptide eluted from class II polypeptides. Proc. Natl. Acad. Sci. USA. 90:9703-9706.
24. Peterson, M., and J. Miller. 1992 Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41. Nature (Lond.). 357:596-598.
25. Anderson, M.S., K. Swier, L. Arneson, and J. Miller. 1993. Enhanced antigen presentation in the absence of the invariant chain endosomal localization signal. J. Exp. Med. 178:1959-1969.
26. Naujokas, M.F., M. Morin, M.S. Anderson, M. Peterson, and J. Miller. 1993. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell. 74:257-268.
27. Ogrinc, T., I. Dolenc, A. Ritonja, and V. Turk. 1993. Purification of the complex of cathepsin L and the MHC class II-associated invariant chain fragment from human kidney. FEBS (Fed. Eur. Biochem. Soc.) Lett. 336:555-559.
28. Turk, B., I. Dolenc, V. Turk, and J.G. Bieth. 1993. Kinetics of the pH-induced inactivation of human cathepsin L. Biochemistry. 32:375-380.
29. Turk, V., and W. Bode. 1993. Lysosomal cysteine proteinases and their inhibitors cystatins. In Innovations in Proteases and Their Inhibitors. Walter de Gruyter, Berlin. 161-178.
30. Dolenc, I., B. Turk, G. Pungerčič, A. Ritonja, and V. Turk. 1995. Ohgomenc structure and substrate induced inhibition of human cathepsin C. J. Biol Chem. 270:21626-21631.
31. Smith, R., and V. Turk. 1974. Cathepsin D: rapid isolation by affinity chromatography on haemoglobin-agarose resin. Eur. J. Biochem. 48:245-254.
32. Morrison, J.F., and C.T. Walsh. 1988. The behavior and significance of slow-binding enzyme inhibitors. Adv. Enzymol. Relat. Areas Mol. Biol. 61:201-301.
33. Morrison, J.F. 1982. The slow-binding and slow, tight-binding inhibition of enzyme-catalysed reactions. Trends Biochem. Sci. 7:102-105.
34. Dixon, M., and E. Webb. 1979. Enzyme inhibition and activation. In The Enzymes. Academic Press, New York. 350-351.
35. Katunuma, N., H. Kakegawa, Y. Matsunaga, and T. Saibara. 1994. Immunological significances of invariant chain from the aspect of its structural homology with the cystatin super-family. FEBS (Fed. Eur. Biochem. Soc.) Lett 349:265-269.
36. Guagliardi, L E., B. Koppelman, J.S. Blum, M.S. Marks, P. Cresswell, and F.M. Brodsky. 1990. Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment. Nature (Lond.). 343:133-139.
37. Romagnoli, P , C. Layet, J. Yewdell, O. Bakke, and R.N. Germain. 1993. Relationship between invariant chain expression and MHC class II transport into early and late endocytic compartments. J. Exp. Med 177.583-596.
38. Arunachalam, B., C.A. Lamb, and P. Cresswell. 1994. Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain. Int. Immunol. 6:439-451.
39. Ludwig, T., G. Griffiths, and B. Hoflack. 1991. Distribution of newly synthesized lysosomal enzymes in the endocytic pathway of normal rat kidney cells. J. Cell Biol. 115:1561-1572.
40. Turk, V., and W. Bode. 1991. The cystatins: protein inhibitors of cysteine proteinases. FEBS (Fed. Eur. Biochem. Soc.) Lett. 285:213-219.
41. Rodriguez, G.M., and S. Diment. 1995. Destructive proteolysis by cysteine proteases in antigen presentation of ovalbumin. Eur. J. Immunol. 25:1823-1827.
42. Nakae, H., M. Sugano, Y. Ishimori, T. Endo, and T. Obinata. 1993. Ascidian entactin/nidogen. Implication of evolution by shuffling two kinds of cysteine-rich motifs. Eur. J. Biochem. 213:11-19.
43. Morabito, M.A., and E. Moczydlowski. 1994. Molecular cloning of bullfrog saxiphilin: a unique relative of the transferrin family that binds saxitoxin. Proc. Natl. Acad. Sci. USA. 91:2478-2482.
44. Matsunaga, Y., T. Saibara, H. Kido, and N. Katunuma. 1993. Participation of cathepsin B in processing of antigen presentation to MHC class II. FEBS (Fed. Eur. Biochem. Soc.) Lett. 324:325-330.
45. Muno, D., N. Sutoh, T. Watanabe, Y. Uchiyama, and E. Kominami. 1990. Effect of metabolic alterations on the density and the contents of cathepsins B, H and L of lysosomes in rat macrophages. Eur. J. Biochem. 191:91-98.